DYN Dyne Therapeutics, Inc.
DYN Dyne Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
POC $18.16 · VWAP $19.58 · -27.2% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $65.2M sold last open-market sell Rhodes Jason P
Cluster CEO, CFO + 3 others sold $65.4M, Aug 17
Coverage
1 watchlist
DYN Price Structure
Loading timeframes…
Peers
Every watchlist DYN belongs to, members best 30-day change first — DYN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $-1.08 versus analyst consensus of $-0.75 (-44.3%).
full note →Against street estimates
How DYN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about DYN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 25 days ago · Sep 22
- Dyne Therapeutics (DYN) Stock Price & Overview
- Dyne Therapeutics (DYN) Stock Price, News & Analysis
- DYN earnings - Dyne Therapeutics Inc. earnings dates & releases | Quantisnow
- DYN Earnings - Dyne Therapeutics Inc. earnings announcements
- Dyne Therapeutics Inc Stock Price Today | NASDAQ: DYN Live - Investing.com
DYN research tape
36 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.